Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q1

Drug Metabolism Reviews

United KingdomPharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)ISSN-matched source record
Q1Ranking
—Impact Factor (year unverified)
117H-index (SCImago 2025)
0.93SJR (2025)
1972, 1974-2026Coverage

About Drug Metabolism Reviews

Drug Metabolism Reviews is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q1, with an SJR of 0.93 and H-index of 117.

Coverage: 1972, 1974-2026. Research categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2).

Source-backed journal facts

ISSN(s)0360-2532, 1097-9883
ISSN-L0360-2532
Source typeJournal
Publisher / hosting organisationTaylor & Francis
Publisher country codeUS
Fully open access (OpenAlex)Not marked as fully open access; hybrid options may exist
DOAJ flag (OpenAlex)Not listed in OpenAlex metadata; this is not a direct DOAJ check
Works recorded in OpenAlex1,815
Citations recorded in OpenAlex90,550
OpenAlex H-index145
Years represented in OpenAlex1972–2026 (not the founding or closing dates)

Topics in published research

Pharmacogenetics and Drug Metabolism; Drug Transport and Resistance Mechanisms; Drug-Induced Hepatotoxicity and Protection; Computational Drug Discovery Methods; Carcinogens and Genotoxicity Assessment; Eicosanoids and Hypertension Pharmacology.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit